Article info

Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study

Authors

  • Ingrid Hougen Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Reid H Whitlock Chronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Paul Komenda Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, CanadaChronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Claudio Rigatto Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, CanadaChronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Kristin K Clemens Institute for Clinical Evaluative Sciences, Toronto, Ontario, CanadaLawson Health Research Institute, London, Ontario, Canada PubMed articlesGoogle scholar articles
  • Navdeep Tangri Department of Internal Medicine, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, CanadaChronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Reid H Whitlock; rwhitlock{at}sogh.mb.ca
View Full Text

Citation

Hougen I, Whitlock RH, Komenda P, et al
Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study

Publication history

  • Received April 27, 2021
  • Accepted November 26, 2021
  • First published December 30, 2021.
Online issue publication 
December 30, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.